Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial. This is an ASCO Meeting Abstract from the 2021 ASCO ...
The World Health Organization estimated 528,000 new cervical cancer occurrences and 266,000 deaths globally each year, which makes it the fourth most common cancer in women. 1 Nine (87%) of 10 ...
Background A 28-year-old Hispanic gravida 1 was found to have a 4–5 cm cervical mass when she presented at 23 weeks gestation. On pelvic examination, the tumor was shown to encompass the entire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results